Literature DB >> 23935330

Ilio-femoral by-pass in a patient with heparin-induced thrombocytopaenia (HIT).

Tt Papas1, I Kotsikoris, D Maras, N Bessias.   

Abstract

Entities:  

Keywords:  HIT; ilio-femoral by-pass; leg ischemia

Year:  2012        PMID： 23935330      PMCID： PMC3738625     

Source DB:  PubMed          Journal:  Hippokratia        ISSN： 1108-4189            Impact factor:   0.471


× No keyword cloud information.
  5 in total

1.  Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.

Authors:  Andreas Koster; Cornelius M Dyke; Gabriel Aldea; Nicholas G Smedira; Harry L McCarthy; Solomon Aronson; Roland Hetzer; Edwin Avery; Bruce Spiess; A Michael Lincoff
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

Review 2.  Fondaparinux: does it cause HIT? Can it treat HIT?

Authors:  Theodore E Warkentin
Journal:  Expert Rev Hematol       Date:  2010-10       Impact factor: 2.929

3.  Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?

Authors:  Theodore E Warkentin; Jo-Ann I Sheppard; Jane C Moore; Kathleen M Moore; Christopher S Sigouin; John G Kelton
Journal:  J Lab Clin Med       Date:  2005-12

4.  Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease.

Authors:  Suzanne J Baron; Robert W Yeh; Ignacio Cruz-Gonzalez; Josephine L Healy; Eugene Pomerantsev; Joseph Garasic; Douglas Drachman; Kenneth Rosenfield; Ik-Kyung Jang
Journal:  Catheter Cardiovasc Interv       Date:  2008-07-01       Impact factor: 2.692

5.  Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia.

Authors:  Ulku C Turba; Ugur Bozlar; Serkan Simsek
Journal:  Catheter Cardiovasc Interv       Date:  2007-12-01       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.